These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 16754783

  • 1. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse.
    Kato Y, Sugiura M, Sugiura T, Wakayama T, Kubo Y, Kobayashi D, Sai Y, Tamai I, Iseki S, Tsuji A.
    Mol Pharmacol; 2006 Sep; 70(3):829-37. PubMed ID: 16754783
    [Abstract] [Full Text] [Related]

  • 2. Carnitine/organic cation transporter OCTN2 (Slc22a5) is responsible for renal secretion of cephaloridine in mice.
    Kano T, Kato Y, Ito K, Ogihara T, Kubo Y, Tsuji A.
    Drug Metab Dispos; 2009 May; 37(5):1009-16. PubMed ID: 19220985
    [Abstract] [Full Text] [Related]

  • 3. PDZK1 regulates two intestinal solute carriers (Slc15a1 and Slc22a5) in mice.
    Sugiura T, Kato Y, Wakayama T, Silver DL, Kubo Y, Iseki S, Tsuji A.
    Drug Metab Dispos; 2008 Jun; 36(6):1181-8. PubMed ID: 18322073
    [Abstract] [Full Text] [Related]

  • 4. Functional characterization of intestinal L-carnitine transport.
    Durán JM, Peral MJ, Calonge ML, Ilundáin AA.
    J Membr Biol; 2002 Jan 01; 185(1):65-74. PubMed ID: 11891565
    [Abstract] [Full Text] [Related]

  • 5. Genetic deficiency of carnitine/organic cation transporter 2 (slc22a5) is associated with altered tissue distribution of its substrate pyrilamine in mice.
    Kato S, Kato Y, Nakamura T, Sugiura T, Kubo Y, Deguchi Y, Tsuji A.
    Biopharm Drug Dispos; 2009 Dec 01; 30(9):495-507. PubMed ID: 19821448
    [Abstract] [Full Text] [Related]

  • 6. OCTN3: A Na+-independent L-carnitine transporter in enterocytes basolateral membrane.
    Durán JM, Peral MJ, Calonge ML, Ilundáin AA.
    J Cell Physiol; 2005 Mar 01; 202(3):929-35. PubMed ID: 15389639
    [Abstract] [Full Text] [Related]

  • 7. Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2.
    Inano A, Sai Y, Nikaido H, Hasimoto N, Asano M, Tsuji A, Tamai I.
    Biopharm Drug Dispos; 2003 Nov 01; 24(8):357-65. PubMed ID: 14595704
    [Abstract] [Full Text] [Related]

  • 8. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein.
    Ohashi R, Tamai I, Inano A, Katsura M, Sai Y, Nezu J, Tsuji A.
    J Pharmacol Exp Ther; 2002 Sep 01; 302(3):1286-94. PubMed ID: 12183691
    [Abstract] [Full Text] [Related]

  • 9. Loss of wild-type carrier-mediated L-carnitine transport activity in hepatocytes of juvenile visceral steatosis mice.
    Yokogawa K, Yonekawa M, Tamai I, Ohashi R, Tatsumi Y, Higashi Y, Nomura M, Hashimoto N, Nikaido H, Hayakawa J, Nezu J, Oku A, Shimane M, Miyamoto K, Tsuji A.
    Hepatology; 1999 Oct 01; 30(4):997-1001. PubMed ID: 10498652
    [Abstract] [Full Text] [Related]

  • 10. PDZ adaptor protein PDZK2 stimulates transport activity of organic cation/carnitine transporter OCTN2 by modulating cell surface expression.
    Watanabe C, Kato Y, Sugiura T, Kubo Y, Wakayama T, Iseki S, Tsuji A.
    Drug Metab Dispos; 2006 Nov 01; 34(11):1927-34. PubMed ID: 16896066
    [Abstract] [Full Text] [Related]

  • 11. PDZK1 directly regulates the function of organic cation/carnitine transporter OCTN2.
    Kato Y, Sai Y, Yoshida K, Watanabe C, Hirata T, Tsuji A.
    Mol Pharmacol; 2005 Mar 01; 67(3):734-43. PubMed ID: 15523054
    [Abstract] [Full Text] [Related]

  • 12. Expression of OCTN2 and OCTN3 in the apical membrane of rat renal cortex and medulla.
    Cano MM, Calonge ML, Ilundain AA.
    J Cell Physiol; 2010 May 01; 223(2):451-9. PubMed ID: 20112288
    [Abstract] [Full Text] [Related]

  • 13. Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells.
    Elimrani I, Lahjouji K, Seidman E, Roy MJ, Mitchell GA, Qureshi I.
    Am J Physiol Gastrointest Liver Physiol; 2003 May 01; 284(5):G863-71. PubMed ID: 12684216
    [Abstract] [Full Text] [Related]

  • 14. Expression and localization of carnitine/organic cation transporter OCTN1 and OCTN2 in ocular epithelium.
    Garrett Q, Xu S, Simmons PA, Vehige J, Flanagan JL, Willcox MD.
    Invest Ophthalmol Vis Sci; 2008 Nov 01; 49(11):4844-9. PubMed ID: 18641280
    [Abstract] [Full Text] [Related]

  • 15. Carnitine transport by organic cation transporters and systemic carnitine deficiency.
    Lahjouji K, Mitchell GA, Qureshi IA.
    Mol Genet Metab; 2001 Aug 01; 73(4):287-97. PubMed ID: 11509010
    [Abstract] [Full Text] [Related]

  • 16. Expression and distribution of OCTN2 in mouse epididymis and its association with obstructive azoospermia in juvenile visceral steatosis mice.
    Yakushiji K, Kai S, Yamauchi M, Kuwajima M, Osada Y, Toshimori K.
    Int J Urol; 2006 Apr 01; 13(4):420-6. PubMed ID: 16734862
    [Abstract] [Full Text] [Related]

  • 17. Functional expression of carnitine/organic cation transporter OCTN1/SLC22A4 in mouse small intestine and liver.
    Sugiura T, Kato S, Shimizu T, Wakayama T, Nakamichi N, Kubo Y, Iwata D, Suzuki K, Soga T, Asano M, Iseki S, Tamai I, Tsuji A, Kato Y.
    Drug Metab Dispos; 2010 Oct 01; 38(10):1665-72. PubMed ID: 20601551
    [Abstract] [Full Text] [Related]

  • 18. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.
    Wu X, Huang W, Prasad PD, Seth P, Rajan DP, Leibach FH, Chen J, Conway SJ, Ganapathy V.
    J Pharmacol Exp Ther; 1999 Sep 01; 290(3):1482-92. PubMed ID: 10454528
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21).
    Tamai I.
    Biopharm Drug Dispos; 2013 Jan 01; 34(1):29-44. PubMed ID: 22952014
    [Abstract] [Full Text] [Related]

  • 20. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.
    Ohashi R, Tamai I, Nezu Ji J, Nikaido H, Hashimoto N, Oku A, Sai Y, Shimane M, Tsuji A.
    Mol Pharmacol; 2001 Feb 01; 59(2):358-66. PubMed ID: 11160873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.